Lupin, Ltd. vs. Horizon Therapeutics, LLC
Explore the PTAB proceeding IPR2018-00459 filed by Lupin, Ltd. on 2018-01-12. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-00459
Filing Date
2018-01-12
Accorded Filing Date
2018-01-12
Institution Decision Date
β
Last Modified Date
2020-02-10
Proceeding Type
IPR
Termination Date
2018-07-25
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Lupin, Ltd.
Represented By
Elizabeth HollandPatent Owner / Respondent
Horizon Therapeutics, LLC
Represented By
Robert GreenPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34547 | Dennis Bennett | +1 314-812-8018 |
| 52062 | Gina Nellesen | +1 650-703-9097 |
| 53459 | Wendy Petka | +1 510-241-0839 |
| 59735 | Cynthia Hathaway | +1 877-812-8020 |
| 61601 | Michael Sertic | +1 314-812-8020 |
| 65040 | Brock Levin | +1 913-787-3513 |
| 70012 | Erin Heenan | +1 202-772-8525 |
| 72123 | Stephanie Greer | +1 214-803-1130 |
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 9,561,197 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2017026614 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2018001505 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2018026393 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012616362 | US Continuation / Sibling | View Official Patent → |
Par Pharmaceutical, Inc. v. Horizon Therapeutics, LLC